Lymphocyte Transfusion
-
Subject Areas on Research
- Alemtuzumab for the prevention and treatment of graft-versus-host disease.
- CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin.
- Development of pemphigus vulgaris-like lesions in severe combined immunodeficiency disease mice reconstituted with lymphocytes from patients.
- Effects of donor splenocytes treated with mitomycin C on rat hepatic, cardiac, and intestinal allografts.
- Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency.
- Graft-versus-host reactions: anti-leukemia effects of donor T cells.
- Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome.
- Improved strategy for mononuclear cell collection for donor lymphocyte infusions.
- In vivo evaluation of cell mediated immunity against human melanoma.
- Inactivated whole SIV vaccine in macaques: evaluation of protective efficacy against challenge with cell-free virus or infected cells.
- Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells.
- Management of recurrent melanoma of the extremity.
- Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation.
- Oral feeding with pig peripheral lymphocytes decreases the xenogeneic delayed type hypersensitivity reaction in galactosyltransferase knockout mice.
- Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation.
- PG27, an extract of Tripterygium wilfordii hook f, induces antigen-specific tolerance in bone marrow transplantation in mice.
- Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation.
- Post-transplantation B cell function in different molecular types of SCID.
- Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
- Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer.
- Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors.
- Surrogate tolerogenesis: possible pretransplant induction of accommodation of pig xenografts.
- Variable allograft responses to pretreatment with donor splenocytes treated with mitomycin C in the rat.
- gammadelta T cells: a new frontier for immunotherapy?